News
Non-Opioid Chronic Pain Therapy Exilby Secures German Authorization
Therapeutic innovation in chronic pain: VERTANICAL’s Exilby has shown superior pain reduction and better gastrointestinal tolerability than opioids in Phase 3 study.

